July 23, 2024CorporateMicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured AneurysmsMicroVention is Also Celebrating the Five-Year Anniversary of its WEB™ Aneurysm Embolization System with more than 10,000 Units Sold in the United States
July 11, 2024FinancialNotice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 142.31 KB)
July 11, 2024FinancialNotice Concerning the Issuance of Stock Options (Share Warrants) (PDF 114.67 KB)
The Latest Materials Financial Results for FYE 3/2024 May 14, 2024 Financial Statements IFRS Financial Results for the Fiscal Year Ended March 31, 2024 (PDF 482.92 KB) Presentation Material The Future of Terumo "Our vision and the path to it" (PDF 1.54 MB) Financial Results for the Fiscal Year Ended March 31, 2024 (FY2023) (PDF 1.38 MB) Financial Results for the Fiscal Year Ended March 31, 2024 (FY2023)(with note) (PDF 769.2 KB) Additional Information Corporate Data File (PDF 615.46 KB) Corporate Data File (Excel 390.96 KB) Q&A Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2024 (PDF 161.49 KB) Webcast Listen to the Webcast Financial Statements /investors/library/financial-statements Presentations /investors/library/presentations Terumo Report /investors/library/annual-reports Sustainability /sustainability Corporate Governance /about/governance Consolidated Financial Statements /investors/library/financial Adobe Reader is required for viewing PDF files. Download Adobe Reader
Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2024 (PDF 161.49 KB)